Product Information
PROLENSA 0.07% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $115.4909 per ML under NDC 24208060203. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Bromfenac Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.7 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208060203
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA203168On Market Since
4/5/2013
Pharmacological Classes
Price Statistics
The NADAC for PROLENSA 0.07% EYE DROPS has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 108.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $115.4909 per ML |
|---|---|
| All-time high | $115.9006 (May 14, 2025) |
| All-time low | $55.3975 (Nov 28, 2013) |
| 52-week high | $115.7122 |
| 52-week low | $115.4578 |
| Median price | $90.2621 |
| Average price | $89.2966 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PROLENSA 0.07% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for PROLENSA 0.07% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $115.4909 per ML (NDC 24208060203), effective Jun 24, 2026.
How has the price of PROLENSA 0.07% EYE DROPS changed over time?
Over the history we have for it, the NADAC for PROLENSA 0.07% EYE DROPS has risen 108.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROLENSA 0.07% EYE DROPS?
Since Nov 28, 2013, the NADAC for PROLENSA 0.07% EYE DROPS has ranged from a low of $55.3975 (Nov 28, 2013) to a high of $115.9006 (May 14, 2025), with a median of $90.2621 per ML.
Are there cheaper alternatives to PROLENSA 0.07% EYE DROPS?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BROMFENAC SODIUM 0.07% EYE DRP, is $12.9679 per ML — about 89% below PROLENSA 0.07% EYE DROPS.
Who manufactures PROLENSA 0.07% EYE DROPS?
PROLENSA 0.07% EYE DROPS (NDC 24208060203) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification